IRCT20200623047902N30尚未招募Unknown
Bioequivalence study of Sodium valproate sodium 200mg tablet manufactured by Ronak Pharm versus originator brand in healthy volunteers in the fasted condition
Ronak Pharm company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcohol and drug addiction
- •History of allergy to Sodium Valproate
研究者
相似试验
已完成
不适用
Bioequivalence study of Sodium Valproate 500 mg ER Tablet in 24 healthy male under fasting conditionsIRCT20180620040164N14Abian Pharmed Co.26
已完成
2 期
The effect of valproate sodium on treatment of patients with maniabipolarity- mania episode.Manic episodeIRCT201108087260N1Vice chancellor of research and technology & Research institute for behavioral disorder and substanc60
已完成
不适用
Comparison of the effect of sodium valproate, levetiracetam, and lamotrigine on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsyjuvenile myoclonic epilepsy.Generalized idiopathic epilepsy and epileptic syndromesIRCT201509079014N79Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences105
尚未招募
3 期
Comparison of the Sodium valproate and Sodae herbal capsule side effects in migraine patientsMigraine.Other disorders of nervous systemG98.8IRCT20200126046272N2Kermanshah University of Medical Sciences90
招募中
3 期
Comparison of the Sodium valproate and Sodae herbal capsule effects on migraine paiMigraineIRCT20200126046272N3Booali Daroo pharmaceutical company90